
Tilda Research offers clinical trial research and an AI-enabled platform that simplifies trial operations to speed drug development and reduce time and cost. The company runs phase I–IV clinical trials and provides Tilda Sense, an AI teammate that integrates with clinical software to automate study setup, routine management tasks, and closeout. Tilda combines traditional clinical research services with clinical-trial SaaS, serving pharmaceutical sponsors and CROs and integrating via APIs with trial management systems and EHRs. Key technologies include machine learning-based automation, workflow orchestration, and API integrations to clinical systems. Tilda Research targets pharma and biotech organizations seeking faster, more efficient clinical development across multiple indications.

Tilda Research offers clinical trial research and an AI-enabled platform that simplifies trial operations to speed drug development and reduce time and cost. The company runs phase I–IV clinical trials and provides Tilda Sense, an AI teammate that integrates with clinical software to automate study setup, routine management tasks, and closeout. Tilda combines traditional clinical research services with clinical-trial SaaS, serving pharmaceutical sponsors and CROs and integrating via APIs with trial management systems and EHRs. Key technologies include machine learning-based automation, workflow orchestration, and API integrations to clinical systems. Tilda Research targets pharma and biotech organizations seeking faster, more efficient clinical development across multiple indications.